72 related articles for article (PubMed ID: 7562019)
1. Cisplatin increases sensitivity of human leukemic blasts to triazene compounds.
Piccioni D; D'Atri S; Papa G; Caravita T; Franchi A; Bonmassar E; Graziani G
J Chemother; 1995 Jun; 7(3):224-9. PubMed ID: 7562019
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic effects of dacarbazine in patients with acute myelogenous leukemia: a pilot study.
Franchi A; Papa G; D'Atri S; Piccioni D; Masi M; Bonmassar E
Haematologica; 1992; 77(2):146-50. PubMed ID: 1398299
[TBL] [Abstract][Full Text] [Related]
3. Chemosensitivity to triazene compounds and O6-alkylguanine-DNA alkyltransferase levels: studies with blasts of leukaemic patients.
D'Atri S; Piccioni D; Castellano A; Tuorto V; Franchi A; Lu K; Christiansen N; Frankel S; Rustum YM; Papa G
Ann Oncol; 1995 Apr; 6(4):389-93. PubMed ID: 7619755
[TBL] [Abstract][Full Text] [Related]
4. Triazene compounds induce apoptosis in O6-alkylguanine-DNA alkyltransferase deficient leukemia cell lines.
Tentori L; Graziani G; Gilberti S; Lacal PM; Bonmassar E; D'Atri S
Leukemia; 1995 Nov; 9(11):1888-95. PubMed ID: 7475280
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of O6-alkylguanine DNA-alkyltransferase or poly(ADP-ribose) polymerase increases susceptibility of leukemic cells to apoptosis induced by temozolomide.
Tentori L; Orlando L; Lacal PM; Benincasa E; Faraoni I; Bonmassar E; D'Atri S; Graziani G
Mol Pharmacol; 1997 Aug; 52(2):249-58. PubMed ID: 9271347
[TBL] [Abstract][Full Text] [Related]
6. O6-alkylguanine-DNA alkyltransferase attenuates triazene-induced cytotoxicity and tumor cell immunogenicity in murine L1210 leukemia.
Graziani G; Faraoni I; Grohmann U; Bianchi R; Binaglia L; Margison GP; Watson AJ; Orlando L; Bonmassar E; D'Atri S
Cancer Res; 1995 Dec; 55(24):6231-6. PubMed ID: 8521419
[TBL] [Abstract][Full Text] [Related]
7. In vitro inactivation of human O6-alkylguanine DNA alkyltransferase by antitumor triazene compounds.
Lacal PM; D'Atri S; Orlando L; Bonmassar E; Graziani G
J Pharmacol Exp Ther; 1996 Oct; 279(1):416-22. PubMed ID: 8859021
[TBL] [Abstract][Full Text] [Related]
8. O6-(4-bromothenyl)guanine (PaTrin-2), a novel inhibitor of O6-alkylguanine DNA alkyl-transferase, increases the inhibitory activity of temozolomide against human acute leukaemia cells in vitro.
Turriziani M; Caporaso P; Bonmassar L; Buccisano F; Amadori S; Venditti A; Cantonetti M; D'Atri S; Bonmassar E
Pharmacol Res; 2006 Apr; 53(4):317-23. PubMed ID: 16412662
[TBL] [Abstract][Full Text] [Related]
9. Novel role of triazenes in haematological malignancies: pilot study of Temozolomide, Lomeguatrib and IL-2 in the chemo-immunotherapy of acute leukaemia.
Caporaso P; Turriziani M; Venditti A; Marchesi F; Buccisano F; Tirindelli MC; Alvino E; Garbin A; Tortorelli G; Toppo L; Bonmassar E; D'Atri S; Amadori S
DNA Repair (Amst); 2007 Aug; 6(8):1179-86. PubMed ID: 17500047
[TBL] [Abstract][Full Text] [Related]
10. Triazene compounds in the treatment of acute myeloid leukemia: a short review and a case report.
Bonmassar L; Marchesi F; Pascale E; Franzese O; Margison GP; Bianchi A; D'Atri S; Bernardini S; Lattuada D; Bonmassar E; Aquino A
Curr Med Chem; 2013; 20(19):2389-401. PubMed ID: 23521681
[TBL] [Abstract][Full Text] [Related]
11. The effect of O6-alkylguanine-DNA alkyltransferase and mismatch repair activities on the sensitivity of human melanoma cells to temozolomide, 1,3-bis(2-chloroethyl)1-nitrosourea, and cisplatin.
Pepponi R; Marra G; Fuggetta MP; Falcinelli S; Pagani E; Bonmassar E; Jiricny J; D'Atri S
J Pharmacol Exp Ther; 2003 Feb; 304(2):661-8. PubMed ID: 12538819
[TBL] [Abstract][Full Text] [Related]
12. DNA repair enzymes and cytotoxic effects of temozolomide: comparative studies between tumor cells and normal cells of the immune system.
Pagani E; Pepponi R; Fuggetta MP; Prete SP; Turriziani M; Bonmassar L; Lacal PM; Falcinelli S; Passarelli F; Guadagni F; Alvino E; D'Atri S
J Chemother; 2003 Apr; 15(2):173-83. PubMed ID: 12797396
[TBL] [Abstract][Full Text] [Related]
13. [Experience with using aclarubicin in the treatment of acute leukemia and blast crisis of chronic myeloid leukemia].
Savchenko VG; Isaev VG; Abakumov EM; Khoroshko ND; Turkina AG; Sokolov AN; Viadro MM; Navashin SM
Antibiot Khimioter; 1992 Jul; 37(7):47-9. PubMed ID: 1456812
[TBL] [Abstract][Full Text] [Related]
14. Temozolomide and cisplatin in relapsed/refractory acute leukemia.
Seiter K; Katragadda S; Ponce D; Rasul M; Ahmed N
J Hematol Oncol; 2009 May; 2():21. PubMed ID: 19463179
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of nitrosourea cytotoxicity in human leukemic cells by inactivation of O6-alkylguanine-DNA alkyltransferase.
Gerson SL; Trey JE; Miller K
Cancer Res; 1988 Mar; 48(6):1521-7. PubMed ID: 3162197
[TBL] [Abstract][Full Text] [Related]
16. O(6)-benzylguanine enhances the in vitro immunotoxic activity of temozolomide on natural or antigen-dependent immunity.
Alvino E; Pepponi R; Pagani E; Lacal PM; Nunziata C; Bonmassar E; D'Atri S
J Pharmacol Exp Ther; 1999 Dec; 291(3):1292-300. PubMed ID: 10565854
[TBL] [Abstract][Full Text] [Related]
17. Drug-mediated changes in the susceptibility of human lymphoblastoid B cells to NK-mediated cytolysis: studies with a triazene compound.
D'Atri S; Bonmassar L; Turriziani M; Giuliani A
J Chemother; 1994 Oct; 6(5):328-36. PubMed ID: 7532216
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of CI-973, a platinum analogue, in refractory or relapsed acute leukemia.
Kantarjian HM; Beran M; O'Brien S; Robertson L; Siddik Z; Yoshida M; Yang LY; Rios MB; Keating MJ; Meyer M
Leukemia; 1996 Mar; 10(3):396-401. PubMed ID: 8642853
[TBL] [Abstract][Full Text] [Related]
19. In vitro combined effects of a triazene compound and interferon-beta on natural immunity against lymphoblastoid cells: studies at effector and target cell level.
Bonmassar L; D'Atri S; Turriziani M; Giuliani A
Immunopharmacol Immunotoxicol; 1994 Nov; 16(4):695-715. PubMed ID: 7876468
[TBL] [Abstract][Full Text] [Related]
20. Modulation of the cellular metabolism of cytarabine and fludarabine by granulocyte-colony-stimulating factor during therapy of acute myelogenous leukemia.
Gandhi V; Estey E; Du M; Nowak B; Keating MJ; Plunkett W
Clin Cancer Res; 1995 Feb; 1(2):169-78. PubMed ID: 9815970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
